Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FYSHP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,280
Award facts
- Contract value 100% obligated
- $12,279.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $12,279.64. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to complete by September 30, 2025, with performance at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's substantial federal contract portfolio demonstrates consistent capability in supplying specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Dupixent, used for treating conditions such as atopic dermatitis and eosinophilic asthma, represents one of numerous specialty pharmaceutical products the vendor delivers through its DLA contracts, reinforcing AmerisourceBergen's role as a primary supplier for military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FYSHP?
SPE2DB25FYSHP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FYSHP worth?
The government has obligated $12,280 on SPE2DB25FYSHP.
Is contract SPE2DB25FYSHP an order under another contract?
Yes. SPE2DB25FYSHP is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYSHP competed?
The extent of competition for SPE2DB25FYSHP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award